Print

Depomed, Inc. (DEPO) Announces Allowance of Additional U.S. Patent Covering Gabapentin GRĀ®  
6/17/2008 10:50:29 AM

MENLO PARK, Calif.--(BUSINESS WIRE)--Depomed, Inc. (NASDAQ:DEPO) announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for U.S. patent application number 10/280,309.
//-->